Albert Morales
Overview
Explore the profile of Albert Morales including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
2918
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abadin X, de Dios C, Zubillaga M, Ivars E, Puigros M, Mari M, et al.
Antioxidants (Basel)
. 2025 Jan;
13(12.
PMID: 39765769
A shared hallmark of age-related neurodegenerative diseases is the chronic activation of innate immune cells, which actively contributes to the neurodegenerative process. In Alzheimer's disease, this inflammatory milieu exacerbates both...
2.
Grondal S, Tutusaus A, Boix L, Reig M, Blo M, Hodneland L, et al.
Front Immunol
. 2024 May;
15:1400553.
PMID: 38817615
Background And Aims: Metabolic dysfunction-associated steatohepatitis (MASH) is a significant health concern with limited treatment options. AXL, a receptor tyrosine kinase activated by the GAS6 ligand, promotes MASH through activation...
3.
Tutusaus A, Sanduzzi-Zamparelli M, Boix L, Rider P, Subias S, Garcia de Frutos P, et al.
Cancers (Basel)
. 2024 Apr;
16(8).
PMID: 38672578
During the last decade, tyrosine kinase inhibitors (TKIs) sorafenib and regorafenib have been standard systemic treatments for advanced hepatocellular carcinoma (HCC). Previous data associated sorafenib with inflammasome activation. However, the...
4.
Tutusaus A, Morales A, Garcia de Frutos P, Mari M
Semin Liver Dis
. 2024 Feb;
44(1):99-114.
PMID: 38395061
TAM (TYRO3, AXL, and MERTK) protein tyrosine kinase membrane receptors and their vitamin K-dependent ligands GAS6 and protein S (PROS) are well-known players in tumor biology and autoimmune diseases. In...
5.
Cuno-Gomiz C, de Gregorio E, Tutusaus A, Rider P, Andres-Sanchez N, Colell A, et al.
Biol Sex Differ
. 2023 Nov;
14(1):85.
PMID: 37964320
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is prevalent in Western countries, evolving into metabolic dysfunction-associated steatohepatitis (MASH) with a sexual dimorphism. Fertile women exhibit lower MASLD risk than men,...
6.
Cristobal H, Enjuanes C, Batlle M, Tajes M, Campos B, Francesch J, et al.
J Pers Med
. 2023 Mar;
13(3).
PMID: 36983628
Heart failure (HF) is classified according to the degree of reduction in left ventricular ejection fraction (EF) in HF with reduced, mildly reduced, and preserved EF. Biomarkers could behave differently...
7.
de Dios C, Abadin X, Roca-Agujetas V, Jimenez-Martinez M, Morales A, Trullas R, et al.
Transl Neurodegener
. 2023 Mar;
12(1):10.
PMID: 36895045
Background: Persistent inflammatory response in the brain can lead to tissue damage and neurodegeneration. In Alzheimer's disease (AD), there is an aberrant activation of inflammasomes, molecular platforms that drive inflammation...
8.
Cucarull B, Tutusaus A, Rider P, Hernaez-Alsina T, Cuno C, Garcia de Frutos P, et al.
Cancers (Basel)
. 2022 Feb;
14(3).
PMID: 35158892
Hepatocellular carcinoma (HCC), the most common form of liver cancer, continues to be a serious medical problem with poor prognosis, without major therapeutic improvement for years and increasing incidence. Fortunately,...
9.
Martinez-Bosch N, Cristobal H, Iglesias M, Gironella M, Barranco L, Visa L, et al.
EBioMedicine
. 2022 Jan;
75:103797.
PMID: 34973624
Background: Early diagnosis is crucial for patients with pancreatic ductal adenocarcinoma (PDAC). The AXL receptor tyrosine kinase is proteolytically processed releasing a soluble form (sAXL) into the blood stream. Here...
10.
Cucarull B, Tutusaus A, Hernaez-Alsina T, Garcia de Frutos P, Reig M, Colell A, et al.
Antioxidants (Basel)
. 2021 Sep;
10(9).
PMID: 34572967
Sorafenib and regorafenib, multikinase inhibitors (MKIs) used as standard chemotherapeutic agents for hepatocellular carcinoma (HCC), generate reactive oxygen species (ROS) during cancer treatment. Antioxidant supplements are becoming popular additions to...